Intelligencia AI
Intelligencia AI is a leading AI-driven drug development company dedicated to de-risking clinical development and enhancing decision-making with AI-powered probability of success assessments. They focus on transforming the pharmaceutical industry through innovative solutions, predictive analytics, and transparent AI models to bring groundbreaking therapies to market faster and more efficiently. Their solutions include AI-powered tools for drug development, data curation, predictive analytics, explainable AI, and dynamic benchmarking to support scientific and business decisions.
Industries
Nr. of Employees
medium (51-250)
Intelligencia AI
1234 Innovation Drive, Boston, MA, USA
Products
Predictive probability-of-success model (patented)
A predictive modeling product that computes probability-of-success scores for individual clinical programs, combining curated data, machine-learning algorithms and explainability outputs to inform go/no-go and portfolio decisions.
APIs for programmatic data and model access
Cloud-hosted interfaces that enable customers to retrieve model outputs, access harmonized datasets, and integrate analytics into internal dashboards and toolchains.
Predictive probability-of-success model (patented)
A predictive modeling product that computes probability-of-success scores for individual clinical programs, combining curated data, machine-learning algorithms and explainability outputs to inform go/no-go and portfolio decisions.
APIs for programmatic data and model access
Cloud-hosted interfaces that enable customers to retrieve model outputs, access harmonized datasets, and integrate analytics into internal dashboards and toolchains.
Services
Cloud-delivered ranking and prioritization tools that combine probability estimates with configurable business and clinical criteria to support resource-allocation decisions.
Benchmarking service that provides up-to-date, customizable comparative analyses and filters for clinical programs using harmonized historical and current trial data.
Provision of expertly curated clinical development datasets plus tailored analytics engagements and advisory support to answer program- or portfolio-specific questions.
Data-driven screening and composite-scoring engagements to identify and prioritize acquisition or in-licensing targets using program-level probability assessments and strategic filters.
Cloud-delivered ranking and prioritization tools that combine probability estimates with configurable business and clinical criteria to support resource-allocation decisions.
Benchmarking service that provides up-to-date, customizable comparative analyses and filters for clinical programs using harmonized historical and current trial data.
Provision of expertly curated clinical development datasets plus tailored analytics engagements and advisory support to answer program- or portfolio-specific questions.
Data-driven screening and composite-scoring engagements to identify and prioritize acquisition or in-licensing targets using program-level probability assessments and strategic filters.
Expertise Areas
- Probability-of-success modeling for clinical programs
- Clinical trial signal detection and trial-design optimization
- Dynamic benchmarking and historical phase-transition analysis
- Explainable AI and model interpretability for healthcare analytics
Key Technologies
- Supervised machine learning for clinical outcome prediction
- Explainable AI attribution methods
- Dimensionality reduction and clustering
- Real-world data (RWD) integration
News & Updates
Intelligencia AI used its PTRS assessments to identify oncology programs with strong potential for ASCO 2025, validating its predictive power with positive clinical outcomes.
Intelligencia AI accurately predicted high-potential programs at ASH 2024, demonstrating the reliability of its AI-powered PTRS assessments in early program success prediction.
Discussion on the rapid transformation of pharma through AI, data, and life sciences, highlighting AI’s role in drug discovery, clinical trials, and decision-making.
Summary of AI’s growing role in healthcare, including drug discovery, clinical trial optimization, digital twins, diagnostics, and proactive healthcare.
Intelligencia AI received a U.S. patent for its accurate and transparent probability of success assessments, reinforcing its innovative leadership in AI-driven drug development.
Intelligencia AI used its PTRS assessments to identify oncology programs with strong potential for ASCO 2025, validating its predictive power with positive clinical outcomes.
Intelligencia AI accurately predicted high-potential programs at ASH 2024, demonstrating the reliability of its AI-powered PTRS assessments in early program success prediction.
Discussion on the rapid transformation of pharma through AI, data, and life sciences, highlighting AI’s role in drug discovery, clinical trials, and decision-making.
Summary of AI’s growing role in healthcare, including drug discovery, clinical trial optimization, digital twins, diagnostics, and proactive healthcare.
Intelligencia AI received a U.S. patent for its accurate and transparent probability of success assessments, reinforcing its innovative leadership in AI-driven drug development.